Perimetrics, Inc. Receives FDA Clearance for InnerView® Hardware and to Measure Damping Characteristic of the Periodontium and Associated Fixtures

Data collected will help diagnose tooth and dental implant mobility, an indicator of underlying health issues such as periodontal disease

Redmond, Wash., Sept. 12, 2023 – Perimetrics, Inc., an advanced artificial intelligence (AI) dental diagnostics company, today announced the U.S. Food and Drug Association (FDA) granted clearance for its InnerView® device, including the wireless handpiece, charging base station and disposable tip with embedded smart chips. It also received clearance for InnerView to measure the damping characteristic of the periodontium and its associated fixed structures including teeth and implants. It can be used to provide data to quantify tooth and dental implant mobility. This is the first FDA clearance for Perimetrics’ InnerView, which will be available commercially once it is cleared for additional indications, expected in early 2024.

Tooth mobility is the horizontal or vertical tooth movement beyond what is normal when force is applied. It may be an indicator of periodontal disease or another issue such as inflammation. Through a handheld, wireless handpiece, InnerView utilizes light taps on either a tooth or implant. A sensor on the handpiece detects micro movements invisible to other diagnostic tools. A smart chip is housed in a single-use disposable tip to prevent reuse. HIPAA-compliant data will be captured in nearly real time to detect damage. With the use of proprietary software, data from each tooth will be analyzed, providing the clinician with a better understanding of what is going on inside the tooth. 

“This FDA clearance for the hardware and indication of the damping characteristic is the first step as we seek to revolutionize the way dentistry diagnoses cracks, failing restorations and mobility,” said Robert Hayman, CEO, chairman of Perimetrics. “Mobility in a tooth or dental implant is a great indicator that there may be damage, including periodontal disease or bone loss. Once InnerView is available in the marketplace, it will be an innovative tool to help clinicians detect tooth damage, which has proven to be difficult.”

Current structural diagnostics used in dentistry are minimally effective, leaving many cracks, failing restorations and mobility issues undetected. X-rays primarily detect decay and certain bone-related issues, but rarely identify damage, a problem that is more prevalent than decay. Once InnerView is available commercially to dentists in early 2024, it will be a first-of-its-kind dental diagnostic system that will utilize artificial intelligence to help detect cracks, failing restorations and mobility in teeth. InnerView works by using Quantitative Percussion Diagnostics™ (QPD), a mechanical test that analyzes the structural integrity of teeth and dental implants and utilizes light taps on either a tooth or implant. A sensor on the handpiece detects micromovements and structural defects invisible to other diagnostic tools. Once InnerView is cleared for additional indications, it is anticipated that it will be available regionally to dentists in Q2 2024, with national distribution by the end of 2024.

“Tooth and implant mobility is a common issue I see in my practice,” said Cherilyn Sheets, DDS, director and co-founder of Perimetrics, who also is in private practice in Newport Beach, California. “This indication will advance how we can diagnose mobility in teeth, helping clinicians improve patient outcomes once InnerView is brought to market.”

About Perimetrics, Inc. 
Perimetrics, Inc. is an advanced artificial intelligence (AI) diagnostics company that develops innovative solutions for dentistry. Through our collaborative model, we fuse science, engineering and technology together to develop advanced diagnostics for dentistry, solving the number one issue of undiagnosable cracks and failing restorations. For more information on Perimetrics and InnerView® Technology, visit https://www.perimetrics.ai/

Perimetrics, Inc. Builds Leadership Team with Addition of Alicia Mszyca as Senior Director of Regulatory Affairs

Perimetrics, Inc. Builds Leadership Team with Addition of
Alicia Mszyca as Senior Director of Regulatory Affairs
Medical device industry veteran tapped as company prepares to disrupt dental diagnostics

Perimetrics, Inc. Builds Leadership Team with Addition of


Alicia Mszyca as Senior Director of Regulatory Affairs


Medical device industry veteran tapped as company prepares to disrupt dental diagnostics
Redmond, WA, Aug. 15, 2023 –
Perimetrics, Inc.,
an advanced artificial intelligence (AI) dental diagnostics company, today announced the appointment of
Alicia Mszyca
as senior director of regulatory affairs. In this role, she will oversee the regulatory, quality and technical functions of the company. Mszyca’s 27-year career has focused on the global medical and dental device industries, leading quality management systems, risk mitigation in product and software design, and post-market surveillance. 

“Alicia brings deep global experience in regulatory and compliance for the medical devices industry, most of it in the dental space,” said Robert Hayman, CEO, Chairman of Perimetrics. “Her knowledge is a much-needed addition, strengthening our regulatory capabilities as Perimetrics brings to market an innovative diagnostic tool that will forever change the face of dentistry. Alicia is a fantastic fit for both our team and culture as we continue to grow the company in advance of regulatory approval. We look forward to her having an immediate impact.”

“Alicia brings deep global experience in regulatory and compliance for the medical devices industry, most of it in the dental space,” said Robert Hayman, CEO, Chairman of Perimetrics. “Her knowledge is a much-needed addition, strengthening our regulatory capabilities as Perimetrics brings to market an innovative diagnostic tool that will forever change the face of dentistry. Alicia is a fantastic fit for both our team and culture as we continue to grow the company in advance of regulatory approval. We look forward to her having an immediate impact.”

Mszyca previously served as the director of regulatory affairs and quality assurance at Swift Health Systems, Inc. where she was responsible for all global regulatory compliance and submission strategies, and implemented a quality management system as the company went through its first ISO and MDSAP certification. Prior to that, she was the director, regulatory affairs at Biolase, Inc., serving as the primary contact with the U.S. Food and Drug Administration (FDA) and other regulatory authorities for the company and drove Emergency Use Authorization for ventilators during the COVID-19 pandemic. Mszyca started her career at Kerr Corporation, being promoted to senior manager, global compliance before leaving in 2013. 

Mszyca previously served as the director of regulatory affairs and quality assurance at Swift Health Systems, Inc. where she was responsible for all global regulatory compliance and submission strategies, and implemented a quality management system as the company went through its first ISO and MDSAP certification. Prior to that, she was the director, regulatory affairs at Biolase, Inc., serving as the primary contact with the U.S. Food and Drug Administration (FDA) and other regulatory authorities for the company and drove Emergency Use Authorization for ventilators during the COVID-19 pandemic. Mszyca started her career at Kerr Corporation, being promoted to senior manager, global compliance before leaving in 2013. 
useful sourcereplica watchd-brand phone casesthis post

“Perimetrics is poised to bring disruptive technology to the dental market, and I am very excited to be a part of such an innovative team that is helping to transform the industry,” said Mszyca. “The opportunity to utilize my expertise to bolster the Regulatory Compliance Department of Perimetrics, working closely with regulatory authorities to advance the standard of dental care, is a huge honor.” 

“Perimetrics is poised to bring disruptive technology to the dental market, and I am very excited to be a part of such an innovative team that is helping to transform the industry,” said Mszyca. “The opportunity to utilize my expertise to bolster the Regulatory Compliance Department of Perimetrics, working closely with regulatory authorities to advance the standard of dental care, is a huge honor.” 
About Perimetrics, Inc.


Perimetrics, Inc. is an advanced artificial intelligence (AI) diagnostics company that develops innovative solutions for dentistry. Through our collaborative model, we fuse science, engineering and technology together to develop advanced diagnostics for dentistry, solving the number one issue of undiagnosable cracks and failing restorations. For more information on Perimetrics and InnerView® Technology, visit
https://www.perimetrics.ai/

Perimetrics, Inc. Announces Formation of Clinical Advisory Board with Leading Dental and Oral Care Experts

Perimetrics, Inc. Announces Formation of Clinical Advisory Board with
Leading Dental and Oral Care Experts
Clinical Advisory Board to provide strategic guidance and patient insights
in advance of regulatory approval

Perimetrics, Inc. Announces Formation of Clinical Advisory Board with


Leading Dental and Oral Care Experts


Clinical Advisory Board to provide strategic guidance and patient insights

Clinical Advisory Board to provide strategic guidance and patient insights


in advance of regulatory approval
in advance of regulatory approval
Redmond, WA, July 19, 2023 –
kurdishcentrecheck out hereclick this link here nowlouis vuitton watches replicael bar del tioelfbar irelandelf bar pods
Perimetrics, Inc.,
an advanced artificial intelligence (AI) dental diagnostics company, today announced the creation of its Clinical Advisory Board consisting of industry leaders in general dentistry, endodontics, periodontics and prosthodontics, including experts from Tufts University and
University of Connecticut Health Sciences
as well as those in private practice. Comprised of eight founding members, the Perimetrics Clinical Advisory Board will provide strategic and clinical insights as the company seeks regulatory approval for InnerView® Technology, a first-of-its kind dental diagnostic system to detect cracks, failing restorations and mobility in teeth.

 

“As we bring a new disruptive technology to the dental industry, the Clinical Advisory Board is a crucial element in understanding how InnerView will be utilized in the clinical setting and the needs of patients,” said Robert Hayman, CEO, chairman of Perimetrics. “The Clinical Advisory Board is very invested in guiding Perimetrics through clinical development to the commercial launch, providing real-world insights into the current pain points when detecting tooth damage.”

“As we bring a new disruptive technology to the dental industry, the Clinical Advisory Board is a crucial element in understanding how InnerView will be utilized in the clinical setting and the needs of patients,” said Robert Hayman, CEO, chairman of Perimetrics. “The Clinical Advisory Board is very invested in guiding Perimetrics through clinical development to the commercial launch, providing real-world insights into the current pain points when detecting tooth damage.”

“As we bring a new disruptive technology to the dental industry, the Clinical Advisory Board is a crucial element in understanding how InnerView will be utilized in the clinical setting and the needs of patients,” said Robert Hayman, CEO, chairman of Perimetrics. “The Clinical Advisory Board is very invested in guiding Perimetrics through clinical development to the commercial launch, providing real-world insights into the current pain points when detecting tooth damage.”

 

The Perimetrics Clinical Advisory Board will offer subject-matter expertise and deeper level understanding of the challenges in detecting tooth damage, including cracks, failing restorations and mobility in teeth. The experts will guide the company as it brings InnerView to market, it continues to expand the technology and capabilities, and it develops new and innovative applications.

The Perimetrics Clinical Advisory Board will offer subject-matter expertise and deeper level understanding of the challenges in detecting tooth damage, including cracks, failing restorations and mobility in teeth. The experts will guide the company as it brings InnerView to market, it continues to expand the technology and capabilities, and it develops new and innovative applications.

The Clinical Advisory Board Members include:

The Clinical Advisory Board Members include:

  • Jeffrey B. Dalin, DDS, FACD, FAGD, FICD, FADI – Dr. Dalin practices general dentistry at his private practice in St. Louis. He was the editor of St. Louis Dentistry Magazine for over 20 years and is a spokesperson for the Missouri Dental Association and the Greater St. Louis Dental Society. Dr. Dalin co-founded Give Kids a Smile, which delivers full-service dental care to children who do not have access.
  • Jack L. Ferracane, PhD – Dr. Ferracane is a professor and chair of the Department of Oral Rehabilitation and Biosciences at Oregon Health & Science University, Portland, Oregon. He is a founding fellow and past-President of the Academy of Dental Materials as well as a past-President of the American Association for Dental Research. Dr. Ferracane has conducted extensive research on dental materials science, with a focus on cracks, and has authored or co-authored several textbooks on dental materials and operative dentistry.
  • Robert Kelly, DDS, MS, DMedSc – Dr. Kelly is professor emeritus at the University of Connecticut Health Sciences, Institute of Materials Science where he teaches graduate prosthodontics and biomaterials. He is the vice chairman of the American Dental Association Standards Committee on Dental Products and past president of the American Academy of Fixed Prosthodontics. Dr. Kelly was awarded the Distinguished Scientist Award by the International Association for Dental Research in 2016.
  • Kenneth A. Malament, DDS, MScD – Dr. Malament is a clinical professor of Dental Medicine and Prosthodontics at Tufts University and is currently the president of the Academy of Prosthodontics and past president of the American Academy of Esthetic Dentistry. His full-time practice in Boston is limited to prosthodontics and includes a dental laboratory with master dental technologists. Dr. Malament has been the recipient of numerous awards in prosthodontics including the American College of Prosthodontists’ Clinician/Researcher Award, and the Daniel F. Gordon Award for Lifetime Achievement and Distinguished Lecturer Award.
  • Linda C. Niessen, DMD, MPH, MPP – Dr. Niessen serves as vice provost for Oral Health Affairs at Kansas City University (KCU) and is founding dean and professor for the KCU College of Dental Medicine in Joplin, Missouri. She is a diplomate of the American Board of Dental Public Health and the American Board of Special Care Dentistry. Dr. Niessen was vice president and chief clinical Officer for DENTSPLY International, a dental manufacturing company, where she oversaw the global clinical education and professional relations activities.
  • Clifford J. Ruddle, DDS, FACD, FICD – Dr. Ruddle is the founder and Director of Advanced Endodontics, an educational organization focused on endodontic technologies and techniques, He is an assistant professor of Graduate Endodontics at Loma Linda University and University of California, Los Angeles, as well as an associate clinical professor at University of California, San Francisco. Dr. Ruddle also is a fellow of the American College of Dentists and International College of Dentists.
  • E. Todd Scheyer, DDS, MS – Dr. Scheyer is a board-certified periodontist at Perio Health Professionals in Houston. He currently serves on the board of trustees for the American Academy of Periodontology, is the past-president of the Southwest Society of Periodontists and is past-president-elect of the Texas Society of Periodontists. Dr. Scheyer has received numerous awards for his work including the Clinical Research Award from the American Academy of Periodontology.
  • John West, DDS, MSD – Dr. West is the founder and a practicing endodontist at the Center for Endodontics in Tacoma, Washington and an affiliate associate professor at the University of Washington. He is an associate editor for Endodontic Practice US and serves on the editorial advisory boards of several peer-reviewed journals including The Journal of Esthetic and Restorative Dentistry. Dr. West has authored or co-authored numerous books on endodontics including Esthetic Management of Endodontically Treated Teeth in the third edition of “Esthetics in Dentistry.”
  • Jeffrey B. Dalin, DDS, FACD, FAGD, FICD, FADI – Dr. Dalin practices general dentistry at his private practice in St. Louis. He was the editor of St. Louis Dentistry Magazine for over 20 years and is a spokesperson for the Missouri Dental Association and the Greater St. Louis Dental Society. Dr. Dalin co-founded Give Kids a Smile, which delivers full-service dental care to children who do not have access.
  • Jeffrey B. Dalin, DDS, FACD, FAGD, FICD,
    FADI –
    Dr. Dalin practices general dentistry at his private practice in St. Louis. He was the editor of St. Louis Dentistry Magazine for over 20 years and is a spokesperson for the Missouri Dental Association and the Greater St. Louis Dental Society. Dr. Dalin co-founded Give Kids a Smile, which delivers full-service dental care to children who do not have access.
    Dr. Dalin practices general dentistry at his private practice in St. Louis. He was the editor of St. Louis Dentistry Magazine for over 20 years and is a spokesperson for the Missouri Dental Association and the Greater St. Louis Dental Society. Dr. Dalin co-founded Give Kids a Smile, which delivers full-service dental care to children who do not have access.

  • Jack L. Ferracane, PhD – Dr. Ferracane is a professor and chair of the Department of Oral Rehabilitation and Biosciences at Oregon Health & Science University, Portland, Oregon. He is a founding fellow and past-President of the Academy of Dental Materials as well as a past-President of the American Association for Dental Research. Dr. Ferracane has conducted extensive research on dental materials science, with a focus on cracks, and has authored or co-authored several textbooks on dental materials and operative dentistry.
  • Jack L. Ferracane, PhD –
    Dr. Ferracane is a professor and chair of the Department of Oral Rehabilitation and Biosciences at Oregon Health & Science University, Portland, Oregon.
    He is a founding fellow and past-President of the Academy of Dental Materials as well as a past-President of the American Association for Dental Research. Dr. Ferracane has conducted extensive research on dental materials science, with a focus on cracks, and has authored or co-authored several textbooks on dental materials and operative dentistry.
    He is a founding fellow and past-President of the Academy of Dental Materials as well as a past-President of the American Association for Dental Research. Dr. Ferracane has conducted extensive research on dental materials science, with a focus on cracks, and has authored or co-authored several textbooks on dental materials and operative dentistry.

  • Robert Kelly, DDS, MS, DMedSc – Dr. Kelly is professor emeritus at the University of Connecticut Health Sciences, Institute of Materials Science where he teaches graduate prosthodontics and biomaterials. He is the vice chairman of the American Dental Association Standards Committee on Dental Products and past president of the American Academy of Fixed Prosthodontics. Dr. Kelly was awarded the Distinguished Scientist Award by the International Association for Dental Research in 2016.
  • Robert Kelly, DDS, MS, DMedSc
    – Dr. Kelly is professor emeritus at the University of Connecticut Health Sciences, Institute of Materials Science where he teaches graduate prosthodontics and biomaterials. He is the vice chairman of the American Dental Association Standards Committee on Dental Products and past president of the American Academy of Fixed Prosthodontics.
    Dr. Kelly was awarded the Distinguished Scientist Award by the International Association for Dental Research in 2016.
    Dr. Kelly was awarded the Distinguished Scientist Award by the International Association for Dental Research in 2016.

  • Kenneth A. Malament, DDS, MScD – Dr. Malament is a clinical professor of Dental Medicine and Prosthodontics at Tufts University and is currently the president of the Academy of Prosthodontics and past president of the American Academy of Esthetic Dentistry. His full-time practice in Boston is limited to prosthodontics and includes a dental laboratory with master dental technologists. Dr. Malament has been the recipient of numerous awards in prosthodontics including the American College of Prosthodontists’ Clinician/Researcher Award, and the Daniel F. Gordon Award for Lifetime Achievement and Distinguished Lecturer Award.
  • Kenneth A. Malament, DDS, MScD –
    Dr. Malament is a clinical professor of Dental Medicine and Prosthodontics at Tufts University and is currently the president of the Academy of Prosthodontics and past president of the American Academy of Esthetic Dentistry. His full-time practice in Boston is limited to prosthodontics and includes a dental laboratory with master dental technologists. Dr. Malament has been the recipient of numerous awards in prosthodontics including the American College of Prosthodontists’ Clinician/Researcher Award, and the Daniel F. Gordon Award for Lifetime Achievement and Distinguished Lecturer Award.

  • Linda C. Niessen, DMD, MPH, MPP – Dr. Niessen serves as vice provost for Oral Health Affairs at Kansas City University (KCU) and is founding dean and professor for the KCU College of Dental Medicine in Joplin, Missouri. She is a diplomate of the American Board of Dental Public Health and the American Board of Special Care Dentistry. Dr. Niessen was vice president and chief clinical Officer for DENTSPLY International, a dental manufacturing company, where she oversaw the global clinical education and professional relations activities.
  • Linda C. Niessen, DMD, MPH, MPP –
    Dr. Niessen serves as vice provost for Oral Health Affairs at Kansas City University (KCU) and is founding dean and professor for the KCU College of Dental Medicine in Joplin, Missouri. She is a diplomate of the American Board of Dental Public Health and the American Board of Special Care Dentistry. Dr. Niessen was vice president and chief clinical Officer for DENTSPLY International, a dental manufacturing company, where she oversaw the global clinical education and professional relations activities.

  • Clifford J. Ruddle, DDS, FACD, FICD – Dr. Ruddle is the founder and Director of Advanced Endodontics, an educational organization focused on endodontic technologies and techniques, He is an assistant professor of Graduate Endodontics at Loma Linda University and University of California, Los Angeles, as well as an associate clinical professor at University of California, San Francisco. Dr. Ruddle also is a fellow of the American College of Dentists and International College of Dentists.
  • Clifford J. Ruddle, DDS, FACD, FICD –
    Dr. Ruddle is the founder and Director of Advanced Endodontics, an educational organization focused on endodontic technologies and techniques, He is an assistant professor of Graduate Endodontics at Loma Linda University and University of California, Los Angeles, as well as an associate clinical professor at University of California, San Francisco. Dr. Ruddle also is a fellow of the American College of Dentists and International College of Dentists.
    Dr. Ruddle is the founder and Director of Advanced Endodontics, an educational organization focused on endodontic technologies and techniques, He is an assistant professor of Graduate Endodontics at Loma Linda University and University of California, Los Angeles, as well as an associate clinical professor at University of California, San Francisco. Dr. Ruddle also is a fellow of the American College of Dentists and International College of Dentists.

  • E. Todd Scheyer, DDS, MS – Dr. Scheyer is a board-certified periodontist at Perio Health Professionals in Houston. He currently serves on the board of trustees for the American Academy of Periodontology, is the past-president of the Southwest Society of Periodontists and is past-president-elect of the Texas Society of Periodontists. Dr. Scheyer has received numerous awards for his work including the Clinical Research Award from the American Academy of Periodontology.
  • E. Todd Scheyer, DDS, MS –
    Dr. Scheyer is a board-certified periodontist at Perio Health Professionals in Houston. He currently serves on the board of trustees for the American Academy of Periodontology, is the past-president of the Southwest Society of Periodontists and is past-president-elect of the Texas Society of Periodontists. Dr. Scheyer has received numerous awards for his work including the Clinical Research Award from the American Academy of Periodontology.
    Dr. Scheyer is a board-certified periodontist at Perio Health Professionals in Houston. He currently serves on the board of trustees for the American Academy of Periodontology, is the past-president of the Southwest Society of Periodontists and is past-president-elect of the Texas Society of Periodontists. Dr. Scheyer has received numerous awards for his work including the Clinical Research Award from the American Academy of Periodontology.

  • John West, DDS, MSD – Dr. West is the founder and a practicing endodontist at the Center for Endodontics in Tacoma, Washington and an affiliate associate professor at the University of Washington. He is an associate editor for Endodontic Practice US and serves on the editorial advisory boards of several peer-reviewed journals including The Journal of Esthetic and Restorative Dentistry. Dr. West has authored or co-authored numerous books on endodontics including Esthetic Management of Endodontically Treated Teeth in the third edition of “Esthetics in Dentistry.”
  • John West, DDS, MSD –
    Dr. West is the founder and a practicing endodontist at the Center for Endodontics in Tacoma, Washington and an affiliate associate professor at the University of Washington. He is an associate editor for Endodontic Practice US and serves on the editorial advisory boards of several peer-reviewed journals including The Journal of Esthetic and Restorative Dentistry. Dr. West has authored or co-authored numerous books on endodontics including Esthetic Management of Endodontically Treated Teeth in the third edition of “Esthetics in Dentistry.”

     

    “The current tools for diagnosing tooth damage are so limited in their effectiveness that dentists often feel like they are flying blind,” said Cherilyn Sheets, DDS, director and co-founder of Perimetrics.” Now, we are on the cusp of changing how we as clinicians practice dentistry, providing an innovative solution to finding cracked teeth, failed restorations and abnormal mobility. We are very proud to have assembled such an esteemed group for our Clinical Advisory Board who will work with us to support our mission of solving dentistry’s biggest diagnostic issue.”

    “The current tools for diagnosing tooth damage are so limited in their effectiveness that dentists often feel like they are flying blind,” said Cherilyn Sheets, DDS, director and co-founder of Perimetrics.” Now, we are on the cusp of changing how we as clinicians practice dentistry, providing an innovative solution to finding cracked teeth, failed restorations and abnormal mobility. We are very proud to have assembled such an esteemed group for our Clinical Advisory Board who will work with us to support our mission of solving dentistry’s biggest diagnostic issue.”

    “The current tools for diagnosing tooth damage are so limited in their effectiveness that dentists often feel like they are flying blind,” said Cherilyn Sheets, DDS, director and co-founder of Perimetrics.” Now, we are on the cusp of changing how we as clinicians practice dentistry, providing an innovative solution to finding cracked teeth, failed restorations and abnormal mobility. We are very proud to have assembled such an esteemed group for our Clinical Advisory Board who will work with us to support our mission of solving dentistry’s biggest diagnostic issue.”

     

    About Perimetrics, Inc.


    Perimetrics, Inc. is an advanced artificial intelligence (AI) diagnostics company that develops innovative solutions for dentistry. Through our collaborative model, we fuse science, engineering and technology together to develop advanced diagnostics for dentistry, solving the number one issue of undiagnosable cracks and failing restorations. For more information on Perimetrics and InnerView® Technology, visit
    https://www.perimetrics.ai/

    How AI is Revolutionizing Dental Diagnostics: Insights from Perimetrics

    The Evolution of Dental AI

    AI’s integration into the realm of dentistry has been steadily developing over the years. Initially seen in orthodontics to predict tooth movements during treatment, AI’s role has considerably expanded, particularly in dental imaging and diagnostics.

    The current AI imaging tools excel in:

    • Detecting cavities
    • Gauging periodontal disease
    • Finding pathologies autonomously

    This not only speeds up diagnoses but also alleviates the meticulous task of examining every image by dentists. Furthermore, AI’s application has broadened to Cone Beam Computed Tomography (CBCT) scans, assisting in identifying root canal anatomy and streamlining implant treatment planning.

    Perimetrics: Harnessing the Power of AI

    Leading the AI revolution in dentistry is our innovative product—InnerView. A ground-breaking blend of percussion diagnostics data and AI, InnerView equips dentists to detect cracks, failing restorations, and mobility issues that could otherwise be overlooked. Continue reading “How AI is Revolutionizing Dental Diagnostics: Insights from Perimetrics”

    The website reflects the vision for the future of the InnerView technology and related diagnostics. The information presented may pertain to either prospective technologies currently under clinical evaluation, or, pending FDA clearances. Some claims may not yet have been proven out via clinical studies.